These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 37565303)

  • 41. MAML2 rearrangement in Warthin's tumour: a fluorescent in situ hybridisation study of metaplastic variants.
    Rotellini M; Paglierani M; Pepi M; Franchi A
    J Oral Pathol Med; 2012 Sep; 41(8):615-20. PubMed ID: 22582766
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expanding the Clinicopathologic Spectrum of YAP1::MAML2-Rearranged Thymic Neoplasm.
    Kim EE; Suh YY; Lee SW; Bae JM; Lee K; Lee S; Yun H; Jung KC; Koh J
    Mod Pathol; 2023 Feb; 36(2):100048. PubMed ID: 36853792
    [No Abstract]   [Full Text] [Related]  

  • 43. Type AB thymoma is not a mixed tumor of type A and type B thymomas, but a distinct type of thymoma.
    Miki Y; Hamada K; Yoshino T; Miyatani K; Takahashi K
    Virchows Arch; 2014 Jun; 464(6):725-34. PubMed ID: 24802113
    [TBL] [Abstract][Full Text] [Related]  

  • 44. YAP1-MAML2 fusion in a pediatric NF2-wildtype intraparenchymal brainstem schwannoma.
    Karajannis MA; Li BK; Souweidane MM; Liechty B; Yao J; Benhamida JK; Bale TA; Rosenblum MK
    Acta Neuropathol Commun; 2022 Aug; 10(1):117. PubMed ID: 35986430
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diagnostic and prognostic utility of Mastermind-like 2 (MAML2) gene rearrangement detection by fluorescent in situ hybridization (FISH) in mucoepidermoid carcinoma of the salivary glands.
    Luk PP; Wykes J; Selinger CI; Ekmejian R; Tay J; Gao K; Eviston TJ; Lum T; O'Toole SA; Clark JR; Gupta R
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 May; 121(5):530-41. PubMed ID: 27068311
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Discovery of recurrent structural variants in nasopharyngeal carcinoma.
    Valouev A; Weng Z; Sweeney RT; Varma S; Le QT; Kong C; Sidow A; West RB
    Genome Res; 2014 Feb; 24(2):300-9. PubMed ID: 24214394
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fluorescence in-situ hybridization identifies Mastermind-like 2 (MAML2) rearrangement in odontogenic cysts with mucous prosoplasia: a pilot study.
    Argyris PP; Wehrs RN; García JJ; Koutlas IG
    Histopathology; 2015 May; 66(6):791-7. PubMed ID: 25123064
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Distinct regulations driving YAP1 expression loss in poroma, porocarcinoma and RB1-deficient skin carcinoma.
    Kervarrec T; Frouin E; Collin C; Tallet A; Tallegas M; Pissaloux D; Tirode F; Guyétant S; Samimi M; Gaboriaud P; Touzé A; Schrama D; Houben R; Tabareau-Delalande F; Neuhart A; de la Fouchardière A; Osio A; Cavelier-Balloy B; Laurent-Roussel S; Sohier P; Cyprien T; Balme B; Belzung F; Jullie ML; Cribier B; Battistella M; Macagno N
    Histopathology; 2023 May; 82(6):885-898. PubMed ID: 36720791
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Warthin-like Mucoepidermoid Carcinoma: A Combined Study of Fluorescence In Situ Hybridization and Whole-slide Imaging.
    Ishibashi K; Ito Y; Masaki A; Fujii K; Beppu S; Sakakibara T; Takino H; Takase H; Ijichi K; Shimozato K; Inagaki H
    Am J Surg Pathol; 2015 Nov; 39(11):1479-87. PubMed ID: 26457352
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression and mutation statuses of epidermal growth factor receptor in thymic epithelial tumors.
    Suzuki E; Sasaki H; Kawano O; Endo K; Haneda H; Yukiue H; Kobayashi Y; Yano M; Fujii Y
    Jpn J Clin Oncol; 2006 Jun; 36(6):351-6. PubMed ID: 16762968
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MAML2 rearrangement as a useful diagnostic marker discriminating between Warthin tumour and Warthin-like mucoepidermoid carcinoma.
    Bieńkowski M; Kunc M; Iliszko M; Kuźniacka A; Studniarek M; Biernat W
    Virchows Arch; 2020 Sep; 477(3):393-400. PubMed ID: 32222825
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expression patterns for Bcl-2, EMA, β-catenin, E-cadherin, PAX8, and MIB1 in thymomas.
    Suster D; Miller JA; Pihan G; Mackinnon AC; Suster S
    Mod Pathol; 2021 Oct; 34(10):1831-1838. PubMed ID: 34135467
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Expression of apoptosis-related markers and HER-2/neu in thymic epithelial tumours.
    Pan CC; Chen PC; Wang LS; Lee JY; Chiang H
    Histopathology; 2003 Aug; 43(2):165-72. PubMed ID: 12877732
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MAML2 rearrangement in primary pulmonary mucoepidermoid carcinoma and the correlation with FLT1 expression.
    Zhu F; Wang W; Hou Y; Shi J; Liu Z; He D; Bai C; Li S; Jiang L
    PLoS One; 2014; 9(4):e94399. PubMed ID: 24714697
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diagnostic utility of thymic epithelial markers CD205 (DEC205) and Foxn1 in thymic epithelial neoplasms.
    Nonaka D; Henley JD; Chiriboga L; Yee H
    Am J Surg Pathol; 2007 Jul; 31(7):1038-44. PubMed ID: 17592270
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pediatric meningioma with a Novel MAML2-YAP1 fusion variant: a case report and literature review.
    Zheng X; Guo S; Liu D; Chu J; Li Y; Wang X; Zhang X; Song C; Huang Q
    BMC Pediatr; 2022 Dec; 22(1):694. PubMed ID: 36463108
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comprehensive genomic analysis reveals clinically relevant molecular distinctions between thymic carcinomas and thymomas.
    Girard N; Shen R; Guo T; Zakowski MF; Heguy A; Riely GJ; Huang J; Lau C; Lash AE; Ladanyi M; Viale A; Antonescu CR; Travis WD; Rusch VW; Kris MG; Pao W
    Clin Cancer Res; 2009 Nov; 15(22):6790-9. PubMed ID: 19861435
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expression of p63 in thymomas and normal thymus.
    Dotto J; Pelosi G; Rosai J
    Am J Clin Pathol; 2007 Mar; 127(3):415-20. PubMed ID: 17276940
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expression of P120 catenin, Kaiso, and metastasis tumor antigen-2 in thymomas.
    Wang Y; Li L; Li Q; Xie C; Wang E; Wang E
    Tumour Biol; 2012 Dec; 33(6):1871-9. PubMed ID: 22833212
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Glia maturation factor-beta is produced by thymoma and may promote intratumoral T-cell differentiation.
    Yamazaki H; Tateyama H; Asai K; Fukai I; Fujii Y; Tada T; Eimoto T
    Histopathology; 2005 Sep; 47(3):292-302. PubMed ID: 16115230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.